DocSym
β
Searchsearch
Search
(B18.1) Chronic viral hepatitis b without delta-agent
More details coming soon
5 282 282 in individuals diagnosis chronic viral hepatitis b without delta-agent confirmed
115 407 deaths with diagnosis chronic viral hepatitis b without delta-agent
2% mortality rate associated with the disease chronic viral hepatitis b without delta-agent
Diagnosis chronic viral hepatitis b without delta-agent is diagnosed Men are 18.60% more likely than Women
3 132 448
Men receive the diagnosis chronic viral hepatitis b without delta-agent
64 432 (2.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
2 149 834
Women receive the diagnosis chronic viral hepatitis b without delta-agent
50 975 (2.4 %)Died from this diagnosis.
Risk Group for the Disease chronic viral hepatitis b without delta-agent - Men aged 35-39 and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features chronic viral hepatitis b without delta-agent
Absence or low individual and public risk
Chronic viral hepatitis b without delta-agent - what does this mean
Chronic viral hepatitis b without delta-agent is caused by infection with the hepatitis b virus, which is spread through contact with infected blood or body fluids. the virus can cause liver inflammation and damage, leading to a long-term infection that can last for many years or even a lifetime.
What happens during the disease - chronic viral hepatitis b without delta-agent
Chronic viral hepatitis b is caused by infection with the hepatitis b virus (hbv). the virus is spread through contact with the blood or other body fluids of an infected person. once inside the body, the virus reproduces in the liver and can cause inflammation and damage to the liver cells. over time, the infection can lead to scarring of the liver (cirrhosis) and liver failure. in some cases, it can also lead to liver cancer.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count
- Liver function tests
- Serum immunoglobulin tests
- Serum albumin
- Serum bilirubin
- Serum alanine aminotransferase (ALT)
- Serum aspartate aminotransferase (AST)
- Serum gamma-glutamyltransferase (GGT)
- Serum alkaline phosphatase
- Serum prothrombin time (PT)
- Hepatitis B surface antigen (HBsAg)
- Hepatitis B surface antibody (HBsAb)
- Hepatitis B core antibody (HBcAb)
- Hepatitis B e antigen (HBeAg)
- Hepatitis B e antibody (HBeAb)
- Hepatitis B virus DNA (HBV DNA)
- Ultrasound or CT scan of the abdomen
- Liver biopsy
Treatment and Medical Assistance
Main Goal: To reduce the risk of long-term liver damage and complications.
- Medications, such as antiviral drugs, to reduce the amount of virus in the body
- Lifestyle changes, such as reducing alcohol consumption, avoiding fatty and processed foods, and following a healthy diet
- Regular monitoring of liver function tests
- Vaccination against hepatitis A and hepatitis B
- Regular exercise and stress reduction
- Regular monitoring of liver enzymes
- Regular check-ups with a liver specialist
- Surgery to remove damaged or diseased parts of the liver
7 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Chronic viral hepatitis b without delta-agent - Prevention
Chronic viral hepatitis b without delta-agent can be prevented by avoiding contact with infected individuals, practicing safe sex, avoiding sharing needles, and getting vaccinated. vaccination is the most effective way to prevent hepatitis b, and is recommended for all children and adults who have not yet been vaccinated.